Related Experiment Video
Updated: Jun 17, 2026
07:27
Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Recreational Activities to Reduce Behavioural Symptoms in Dementia
Ann Kolanowski1, Donna M Fick, Linda Buettner
1Elouise Ross Eberly Professor of Nursing, The Pennsylvania State University, University Park, PA, USA.
Geriatrics & Aging
|January 5, 2010
Summary
Recreational activities are effective nonpharmacological interventions for reducing behavioral symptoms in dementia. Implementing these activities requires understanding the evidence, reducing interfering medications, and individualizing plans for maximum benefit.
Area of Science:
- Gerontology
- Psychiatry
- Behavioral Science
Background:
- Limited clinician education exists regarding nonpharmacological therapies for dementia.
- Behavioral symptoms of dementia significantly impact patient well-being and caregiver burden.
Purpose of the Study:
- To explore the utility of recreational activities as a nonpharmacological intervention for dementia.
- To highlight key components for effective implementation of recreational activities.
Main Methods:
- Literature review on the effectiveness of recreational activities.
- Analysis of implementation strategies for nonpharmacological interventions.
Main Results:
- Recreational activities demonstrate effectiveness in reducing behavioral symptoms of dementia.
- Successful implementation hinges on evidence-based understanding, medication management, and personalization.
Conclusions:
- Recreational activities offer a viable nonpharmacological approach to managing dementia symptoms.
- A multi-component strategy is crucial for optimizing the benefits of these interventions.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...